business news in context, analysis with attitude

• With the resignation of Scott Gottlieb, commissioner of the Food and Drug Administration (FDA) scheduled to take effect next month, the Trump administration has named Ned Sharpless, director of the National Cancer Institute, to serve as Acting FDA Commissioner.

Health and Human Services Secretary Alex Azar, in making the announcement said that the appointment means that “there will be no let-up in the agency’s focus, from ongoing efforts on drug approvals and combating the opioid crisis to modernizing food safety and addressing the rapid rise in youth use of e-cigarettes.”
KC's View: